Automation in Pharmacovigilance: Doing More With Less
Partner and Senior Director
Foresight, A QuintilesIMS Company, Canada
The session will provide an overview of the current pharmacovigilance landscape and where the industry stands on automation versus manual processes with respect to adverse event processing, assessing, reporting and signaling. Functional areas will then be presented where companies can employ simple to sophisticated means to automate many of the resource intensive processes that will result in better consistency, higher quality and improved compliance.
Learning Objective : Identify functions or processes that are candidates for improvement within their own pharmacovigilance practice especially through methods of automation; Explain how companies have successfully automated many aspects of the PV process and the benefits as well as liabilities such an automation can bring.
Data Visualization and Analytics for Medical Monitors: Tech Adoption and Best Practices
Masha Hoffey, MS
Director of Clinical Analytics
PerkinElmer Informatics, Inc., United States
Signal Detection in Social Media: Feasibility Assessment of Methods
Neal Grabowski, MS
Signal Management Officer
Amgen Inc., United States